• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

Challenges to Implementing the Info Blocking Rule


New regulations could mean new challenges for health systems.

Although the new interoperability rules could benefit both patients and health systems, new regulations could lead to new barriers that healthcare executives will need to overcome.

Drew Ivan, executive vice president of product and strategy at Rhapsody, spoke with Inside Digital Health™ about the importance of a rule promoting interoperability and challenges that health systems might face when the rule goes into effect.

Editor’s note: The following transcript has been lightly edited for style, length and clarity.

Drew Ivan: I definitely think that one of the biggest benefits of keeping data electronically is the ability to easily transfer them from one location to another. And as a result of migrating to electronic health records, it's really important to be able to do that. So, I think that anything that promotes interoperability is really going to be a big benefit to the industry.

One of the biggest challenges is that the rules aren't quite finalized yet. So, we're not exactly sure what shape they're going to take or what the exact requirements will be. That means that providers will have to be flexible because until the rules are completely specified, it's impossible to know exactly what's going to be required. So, the best you can do is be prepared and get ready for when the real rules take effect.

Get the best insights in digital health directly to your inbox.

Dig Deeper

Understanding and Preparing for the Info Blocking Rule

HITAC Suggests Removing Price Transparency Requirements from Information Blocking Rule

CMS and ONC Propose New Rules to Improve Interoperability of EHI

Related Videos
Jim Adams, AllianceRx Walgreens Prime
Heather Bonome, Pharm.D., URAC
George Van Antwerp, MBA
Jesse Fasolo
Edmondo Robinson, MD, MBA
Edmondo Robinson, MD
Craig Newman
Hilary Babcock, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.